Common allergy drug may heal brain damage in preterm infants
Disease control
Not yet recruiting
This study tests whether clemastine, an allergy medicine, is safe for premature babies with white matter injury—a common brain injury in infants born early. Researchers will give the drug by mouth to 24 babies born at or before 32 weeks and now between 35 and 41 weeks old. The go…
Phase: PHASE1 • Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC